Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Ofloxacin antibody

Reactivity: Chemical ELISA, IC, IEM Host: Mouse Monoclonal unconjugated
Catalog No. ABIN1089713
  • Target
    Ofloxacin
    Reactivity
    • 1
    • 1
    Chemical
    Host
    • 2
    Mouse
    Clonality
    • 2
    Monoclonal
    Conjugate
    • 2
    Un-conjugated
    Application
    • 2
    • 2
    • 2
    • 1
    • 1
    ELISA, Immunochromatography (IC), Immunoelectron Microscopy (IEM)
    Cross-Reactivity (Details)
    no significant cross-reactivity or interference was observed
    Purification
    Caprylic Acid Ammonium Sulfate Precipitation
    Purity
    > 95 %
    Immunogen
    Ofloxacin-BSA conjugate
    Isotype
    IgG2b
  • Application Notes
    Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    0.03 % Proclin 300, 50 % Glycerol, 0.01 M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Handling Advice
    Avoid freeze and thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Shipped at 4 °C Upon delivery aliquot and store at -24 °C or -84 °C.
  • Target
    Ofloxacin
    Target Type
    Chemical
    Background
    Ofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone. The original brand, Floxin, has been discontinued by the manufacturer in the United States on 18 June 2009, though generic equivalents continue to be available. Like other quinolones, ofloxacin has been associated with a significant number of serious adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible).
    Synonyms: Oflocee,oflocet, oflocin, orocin, tarivid
You are here:
Support